Responses
Innovations in Treatment
Case report
Transitioning a patient from injectable opioid agonist therapy to sublingual buprenorphine/naloxone for the treatment of opioid use disorder using a microdosing approach
Compose a Response to This Article
Other responses
No responses have been published for this article.